Multi-Drug Screen Test Cup (Urine)

Multi-Drug Screen Test Cup is a rapid test for qualitative and simultaneous detection of Amphetamine, Barbiturates, Benzodiazepine, Cocaine, MDMA Ecstasy, Marijuana, Methadone, Methamphetamine, Opiates, Oxycodone, Phencyclidine and Propoxyphene in human urine

  • 產(chǎn)品品牌: REAGEN
  • 產(chǎn)品貨號(hào): RDS99037

INTENDED USE

Multi-Drug Screen Test Cup is a rapid test for qualitative and simultaneous detection of Amphetamine, Barbiturates, Benzodiazepine, Cocaine, MDMA Ecstasy, Marijuana, Methadone, Methamphetamine, Opiates, Oxycodone, Phencyclidine and Propoxyphene in human urine at the cutoff concentrations of:

Drug(Identifier)

Cut-off level                        (ng/ml)

Amphetamine(AMP)               1,000

Barbiturates(BARB)                  300

Benzodiazepines(BZO)             200

Cocaine(COC)                             300

MDMA(Ecstasy)                         500

Marijuana(THC)                         20

Methadone(MTD)                      300

Methamphetamine(MET)        500

Opiates(OPI)                            2,000

Oxycodone (OXY)                      100

Pheneyclidine(PCP)                   25

Propoxyphene(PPX)                 300

Configuration of the Multi-Drug Screen Test Cup can consist of any combination of the above listed drug analytes. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a conformed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

The test results can be used to provide evidence and basis for therapy and treatment plans of drug dependence and toxic psychosis. For laboratory professional in vitro diagnostic use only. The test should only be performed by health professionals in a clinical/hospital setting to aid in screening of drug of abuse to determine the follow-up treatment measures in combination of clinical symptoms.

SUMMARY

Amphetamine (AMP)

Amphetamine and the structurally related “designer” drugs are sympathomimetic amines whose biological effects include potent central nervous system (CNS) stimulation, anorectic, hyperthemic, and cardiovascular properties. They are usually taken orally, intraveneously, or by smoking. Amphetamines are readily absorbed from the gastrointestinal tract and are then either deactivated by the liver or excreted unchanged in the urine with a half life of about 12 hours. It can be detected in the urine for 1 to 2 days after use. Amphetamine is metabolized to deaminated (hippuric and benzoic acids) and hydroxylated metabolites. Methamphetamine is partially metabolized to amphetamine and its major active metabolite. Amphetamines increase the heart rate and blood pressure, and suppress the appetite. Some studies indicate that heavy abuse may result in permanent damage to certain essential nerve structural in the brain.


企業(yè)愿景

    公司將一如既往的視誠(chéng)信為最重要的文化精神;在經(jīng)營(yíng)決策和管理的全過程中信守“以產(chǎn)品質(zhì)量、優(yōu)質(zhì)服務(wù)”為原則和“為人類健康服務(wù)”為宗旨的理念;融前沿科技、全球資源與優(yōu)質(zhì)人才為資本,以開拓創(chuàng)新、銳意進(jìn)取、精益求精之精神,科學(xué)管理之導(dǎo)向,凝聚員工、客商之合力,同舟共濟(jì),為實(shí)現(xiàn)人類的食品安全和生物醫(yī)藥業(yè)的高速發(fā)展不懈奮斗!

查看更多

工作時(shí)間

客戶熱線: 0755-2300-6699
工作時(shí)間: 09:00AM-20:00PM一流的專業(yè) 一流的服務(wù)